COX-2s Left Out Of Drug Classes, Will Go Up Against Other NSAIDs

COX-2 inhibitors are among the drugs where Medicare coverage would be "recommended," but not required, under the U.S. Pharmacopeia's model formulary

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet